Clinical Trial Update: Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating BIO-11006 inhalation solution for reducing mucus overproduction and inflammation in chronic obstructive pulmonary disease has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BIO-11006 Inhalation Solution

Snippet

Sponsor: BioMarck Pharmaceuticals, Ltd. | Conditions: COPD, Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED